Leveraging AI to identify dual-purpose aging and disease targets.

Autor: Leung GHD; Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park, Hong Kong, China., Wong CW; Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park, Hong Kong, China., Pun FW; Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park, Hong Kong, China., Aliper A; Insilico Medicine AI Ltd, Abu Dhabi, United Arab Emirates., Ren F; Insilico Medicine Shanghai Ltd, Shanghai, China., Zhavoronkov A; Insilico Medicine Hong Kong Ltd, Hong Kong Science and Technology Park, Hong Kong, China.; Insilico Medicine AI Ltd, Abu Dhabi, United Arab Emirates.; Buck Institute for Research on Aging, Novato, CA, USA.
Jazyk: angličtina
Zdroj: Expert opinion on therapeutic targets [Expert Opin Ther Targets] 2024 Jun; Vol. 28 (6), pp. 473-476. Date of Electronic Publication: 2023 Dec 01.
DOI: 10.1080/14728222.2023.2288270
Databáze: MEDLINE